États-Unis · Plateformes & données · The Motley Fool

Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech?

Publié par The Motley Fool · États-Unis il y a 55 min

Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech? — Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech? · The Motley Fool

Résumé détaillé

The stock has climbed more than 40% in one year.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

À lire aussi

The Grand Theft Auto 6 economy reaches far and wide

Eric Trump-backed robot soldier startup can't pay staff after founder borrowed $4.6 million from company to buy home

Babcock & Wilcox CEO Kenneth Young buys $43,500 in stock

Bernicke Wealth Management Ltd. Makes New Investment in Intel Corporation $INTC

First-time homebuyers are losing ground in U.S. housing market: here’s why

Forget Elon Musk’s Tesla Roadster ‘Rocket’ — a Chinese rival has 7,000+ orders for its nearly $300K flying car, due 2027